{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:28:37Z","timestamp":1789586917920,"version":"build-2803163510"},"reference-count":271,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recently, we have experienced a serious pandemic. Despite significant technological advances in molecular technologies, it is very challenging to slow down the infection spread. It appeared that due to globalization, SARS-CoV-2 spread easily and adapted to new environments or geographical or weather zones. Additionally, new variants are emerging that show different infection potential and clinical outcomes. On the other hand, we have some experience with other pandemics and some solutions in virus elimination that could be adapted. This is of high importance since, as the latest reports demonstrate, vaccine technology might not follow the new, mutated virus outbreaks. Thus, identification of novel strategies and markers or diagnostic methods is highly necessary. For this reason, we present some of the latest views on SARS-CoV-2\/COVID-19 therapeutic strategies and raise a solution based on miRNA. We believe that in the face of the rapidly increasing global situation and based on analogical studies of other viruses, the possibility of using the biological potential of miRNA technology is very promising. It could be used as a promising diagnostic and prognostic factor, as well as a therapeutic target and tool.<\/jats:p>","DOI":"10.3390\/ijms22168663","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:54:41Z","timestamp":1628765681000},"page":"8663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-2079","authenticated-orcid":false,"given":"Maria","family":"Naro\u017cna","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 4 \u015awi\u0119cickiego St., 60-781 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-0176","authenticated-orcid":false,"given":"B\u0142a\u017cej","family":"Rubi\u015b","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, 49 Przybyszewskiego St., 60-355 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2021, August 07). WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/d41586-020-02544-6","article-title":"The coronavirus is mutating\u2014Does it matter?","volume":"585","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117652","DOI":"10.1016\/j.lfs.2020.117652","article-title":"In silico studies on therapeutic agents for COVID-19: Drug repurposing approach","volume":"252","author":"Shah","year":"2020","journal-title":"Life Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/jcp.30032","article-title":"Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies","volume":"236","author":"Seyedpour","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_7","unstructured":"(2021, August 07). FDA Approves First Treatment for COVID-19, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19."},{"key":"ref_8","unstructured":"(2021, August 07). Coronavirus (COVID-19) Drugs FDA, Available online: https:\/\/www.fda.gov\/drugs\/emergency-preparedness-drugs\/coronavirus-covid-19-drugs."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ygeno.2020.09.059","article-title":"Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection","volume":"113","author":"Rahimi","year":"2021","journal-title":"Genomics"},{"key":"ref_10","unstructured":"(2021, April 13). Covid-19 Vaccine: First UK Citizens Receive Shot, a Landmark Moment in the Pandemic\u2013CNN. Available online: https:\/\/edition.cnn.com\/2020\/12\/08\/europe\/uk-pfizer-biontech-covid-vaccination-intl\/index.html."},{"key":"ref_11","unstructured":"(2021, April 13). Get the Facts about COVID-19 Vaccines\u2014Mayo Clinic. Available online: https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/in-depth\/coronavirus-vaccine\/art-20484859."},{"key":"ref_12","unstructured":"(2021, April 13). PANGO Lineages. Available online: https:\/\/cov-lineages.org\/global_report.html."},{"key":"ref_13","unstructured":"(2021, May 15). SARS-CoV-2 Variants of Concern as of 11 May 2021. Available online: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/jmv.26756","article-title":"Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India","volume":"93","author":"Kolte","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jinf.2021.01.007","article-title":"Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK","volume":"82","author":"Tang","year":"2021","journal-title":"J. Infect."},{"key":"ref_16","first-page":"1","article-title":"The British variant of the new coronavirus-19 (SARS-CoV-2) should not create a vaccine problem","volume":"35","author":"Conti","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.icb.7100062","article-title":"The advent of the cytokine storm","volume":"85","author":"Clark","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Bernabei","year":"2020","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hosseini, N., Nadjafi, S., and Ashtary, B. (2021). Overview of COVID-19 and neurological complications. Rev. Neurosci.","DOI":"10.1515\/revneuro-2020-0116"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110055","DOI":"10.1016\/j.mehy.2020.110055","article-title":"Into the looking glass: Post-viral syndrome post COVID-19","volume":"144","author":"Perrin","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","article-title":"A systematic review of asymptomatic infections with COVID-19","volume":"54","author":"Gao","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1007\/s12035-020-02074-2","article-title":"Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection","volume":"57","author":"Bhatti","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40199-020-00359-4","article-title":"Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection","volume":"28","author":"Afshani","year":"2020","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cca.2020.08.013","article-title":"Potential diagnostics and therapeutic approaches in COVID-19","volume":"510","author":"Kumari","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","volume":"15","author":"Hu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Huchting, J. (2020). Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections. Antivir. Chem. Chemother., 28.","DOI":"10.1177\/2040206620976786"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Muhammad, Y., Kani, Y.A., Iliya, S., Muhammad, J.B., Binji, A., El-Fulaty Ahmad, A., Kabir, M.B., Umar Bindawa, K., and Ahmed, A. (2021). Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med., 9.","DOI":"10.1177\/2050312121991246"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Brenner, H., and Sch\u00f6ttker, B. (2020). Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: \u201cVitamin D Deficiency and Outcome of COVID-19 Patients\u201d. Nutrients, 12.","DOI":"10.3390\/nu12123642"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2018.04.032","article-title":"Role of Wnt4\/\u03b2-catenin, Ang II\/TGF\u03b2, ACE2, NF-\u03baB, and IL-18 in attenuating renal ischemia\/reperfusion-induced injury in rats treated with Vit D and pioglitazone","volume":"831","author":"Ali","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_41","first-page":"1","article-title":"SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eabh3032","DOI":"10.1126\/sciadv.abh3032","article-title":"Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies","volume":"7","author":"Han","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-0900-2_1","article-title":"Coronaviruses: An Updated Overview of Their Replication and Pathogenesis","volume":"2203","author":"Wang","year":"2020","journal-title":"Methods in Mol. Biol."},{"key":"ref_45","first-page":"e10480","article-title":"Therapeutic Options for COVID-19: A Review","volume":"12","author":"Pujari","year":"2020","journal-title":"Cureus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","article-title":"Lopinavir\u2013ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"396","author":"Horby","year":"2020","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107940","DOI":"10.1016\/j.celrep.2020.107940","article-title":"Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice","volume":"32","author":"Pruijssers","year":"2020","journal-title":"Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2020006964","article-title":"Use of convalescent plasma in hospitalized patients with COVID-19: Case series","volume":"136","author":"Hegerova","year":"2020","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40264-020-00952-1","article-title":"Remdesivir in Treatment of COVID-19: A Systematic Benefit\u2013Risk Assessment","volume":"43","author":"Davies","year":"2020","journal-title":"Drug Saf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, M.P., Forleo-Neto, E., Musser, B.J., Isa, F., Chan, K.-C., Sarkar, N., Bar, K.J., Barnabas, R.V., Barouch, D.H., and Cohen, M.S. (2021). Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. N. Eng. J. Med.","DOI":"10.1056\/NEJMoa2109682"},{"key":"ref_52","first-page":"4539","article-title":"Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"24","author":"Meo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"Van In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00253-021-11094-4","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19: The never-ending story","volume":"105","author":"Gasmi","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"112739","DOI":"10.1016\/j.ejmech.2020.112739","article-title":"Azithromycin: The First Broad-spectrum Therapeutic","volume":"207","author":"Firth","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"397","author":"Abaleke","year":"2021","journal-title":"Lancet"},{"key":"ref_57","unstructured":"(2021, April 13). Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems, Available online: https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/hydroxychloroquine-or-chloroquine-covid-19-drug-safety-communication-fda-cautions-against-use."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Horby, P., Mafham, M., Linsell, L., Bell, J.L., Staplin, N., Emberson, J.R., Wiselka, M., Ustianowski, A., Elmahi, E., and Prudon, B. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. medRxiv.","DOI":"10.1101\/2020.07.15.20151852"},{"key":"ref_59","first-page":"CD005532","article-title":"Vitamin C for preventing and treating pneumonia","volume":"8","author":"Louhiala","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.574029","article-title":"The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19","volume":"11","author":"Cerullo","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Carr, A.C., and Rowe, S. (2020). The emerging role of vitamin c in the prevention and treatment of covid-19. Nutrients, 12.","DOI":"10.3390\/nu12113286"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Tomasa-Irriguible, T.M. (2020). COVID-19: Up to 87% Critically Ill Patients Had Low Vitamin C Values. Nutr. J.","DOI":"10.21203\/rs.3.rs-89413\/v1"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jgar.2020.09.025","article-title":"Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection","volume":"23","author":"Hoang","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/14787210.2020.1794819","article-title":"The Use of IV vitamin C for patients with COVID-19: A single center observational study","volume":"18","author":"Hiedra","year":"2020","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13054-020-02851-4","article-title":"A new clinical trial to test high-dose vitamin C in patients with COVID-19","volume":"24","author":"Carr","year":"2020","journal-title":"Crit. Care"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., and van Bentum-Puijk, W. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N. Eng. J. Med., 384, 1491\u20131502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nfs.2020.06.001","article-title":"Vitamin D deficiency and co-morbidities in COVID-19 patients\u2014A fatal relationship?","volume":"20","author":"Biesalski","year":"2020","journal-title":"NFS J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100051","DOI":"10.1016\/j.medidd.2020.100051","article-title":"Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation?","volume":"7","author":"Razdan","year":"2020","journal-title":"Med. Drug Discov."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4049\/jimmunol.0902840","article-title":"Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-\u03baB\u2013Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State","volume":"184","author":"Hansdottir","year":"2010","journal-title":"J. Immunol."},{"key":"ref_71","first-page":"208","article-title":"Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis","volume":"113","author":"Campbell","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_72","unstructured":"(2021, April 13). COVID-19 and Vitamin D Supplementation: A Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-Risk COVID-19 Patients, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04344041."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fpubh.2020.00513","article-title":"A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency","volume":"8","author":"Benskin","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sulli, A., Gotelli, E., Casabella, A., Paolino, S., Pizzorni, C., Alessandri, E., Grosso, M., Ferone, D., Smith, V., and Cutolo, M. (2021). Vitamin d and lung outcomes in elderly covid-19 patients. Nutrients, 13.","DOI":"10.3390\/nu13030717"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Brenner, H. (2021). Vitamin D supplementation to prevent COVID-19 infections and deaths\u2014accumulating evidence from epidemiological and intervention studies calls for immediate action. Nutrients, 13.","DOI":"10.3390\/nu13020411"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinmicnews.2021.02.001","article-title":"Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19","volume":"43","author":"Ripoll","year":"2021","journal-title":"Clin. Microbiol. Newsl."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa2031304","article-title":"A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia","volume":"384","author":"Simonovich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2147\/JIR.S301784","article-title":"Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications","volume":"14","author":"Rowaiye","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"m2422","DOI":"10.1136\/bmj.m2422","article-title":"Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds","volume":"369","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaci.2020.05.021","article-title":"Successful use of methylprednisolone for treating severe COVID-19","volume":"146","author":"Liu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2020). Dexamethasone in Hospitalized Patients with Covid-19. N. Eng. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mehta, P., Ciurtin, C., Scully, M., Levi, M., and Chambers, R.C. (2020). JAK inhibitors in COVID-19: The need for vigilance regarding increased inherent thrombotic risk. Eur. Respir. J., 56.","DOI":"10.1183\/13993003.01919-2020"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19","volume":"384","author":"Kalil","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_86","unstructured":"(2021, April 13). The Different Types of COVID-19 Vaccines. Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-race-for-a-covid-19-vaccine-explained."},{"key":"ref_87","unstructured":"(2021, May 29). COVID-19 Vaccine Tracker | RAPS. Available online: https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker."},{"key":"ref_88","unstructured":"(2021, May 15). WHO Says India Covid Variant of \u201cGlobal Concern\u201d. Available online: https:\/\/www.bbc.com\/news\/world-asia-india-57067190."},{"key":"ref_89","unstructured":"(2021, May 15). Coronavirus Variants are Spreading in India\u2014What Scientists Know so Far. Available online: https:\/\/www.nature.com\/articles\/d41586-021-01274-7."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Yadav, P.D., Mohandas, S., Shete, A.M., Nyayanit, D.A., Gupta, N., Patil, D.Y., Sapkal, G.N., Potdar, V., Kadam, M., and Kumar, A. (2021). SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant. bioRxiv.","DOI":"10.1101\/2021.05.05.442760"},{"key":"ref_91","unstructured":"Ferreira, I., Datir, R., Papa, G., Kemp, S., Meng, B., Singh, S., Pandey, R., Ponnusamy, K., Radhakrishnan, V., and Sato, K. (2021). SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies. bioRxiv."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Hofmann-Winkler, H., Kr\u00fcger, N., Kempf, A., Nehlmeier, I., Graichen, L., Sidarovich, A., Moldenhauer, A.-S., Winkler, M.S., and Schulz, S. (2021). SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades 1 antibodies induced by infection and vaccinatio. bioRxiv.","DOI":"10.1101\/2021.05.04.442663"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cherian, S., Potdar, V., Jadhav, S., Yadav, P., Gupta, N., Das, M., Das, S., Agarwal, A., Singh, S., and Abraham, P. (2021). Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. bioRxiv.","DOI":"10.1101\/2021.04.22.440932"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Gupta, R.K. (2021). Will SARS-CoV-2 variants of concern affect the promise of vaccines?. Nat. Rev. Immunol., 1\u20132.","DOI":"10.1038\/s41577-021-00556-5"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mellet, J., and Pepper, M.S. (2021). A COVID-19 Vaccine: Big Strides Come with Big Challenges. Vaccines, 9.","DOI":"10.3390\/vaccines9010039"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Andreadakis","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_97","unstructured":"(2021, April 13). BCG Vaccination to Protect Healthcare Workers against COVID-19, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04327206."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Rivas, M.N., Ebinger, J.E., Wu, M., Sun, N., Braun, J., Sobhani, K., van Eyk, J.E., Cheng, S., and Arditi, M. (2021). BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers. J. Clin. Investig., 131.","DOI":"10.1172\/JCI145157"},{"key":"ref_99","unstructured":"(2021, April 13). COVID-19 Vaccines. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/covid-19-vaccines."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Loo, K.Y., Letchumanan, V., Ser, H.L., Teoh, S.L., Law, J.W.F., Tan, L.T.H., Mutalib, N.S.A., Chan, K.G., and Lee, L.H. (2021). COVID-19: Insights into potential vaccines. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030605"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Callaway, E. (2020). What Pfizer\u2019s landmark COVID vaccine results mean for the pandemic. Nature.","DOI":"10.1038\/d41586-020-03166-8"},{"key":"ref_102","unstructured":"(2021, May 01). Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa. Available online: https:\/\/investors.modernatx.com\/news-releases\/news-release-details\/moderna-covid-19-vaccine-retains-neutralizing-activity-against\/."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Wu, K., Werner, A.P., Moliva, J.I., Koch, M., Choi, A., Stewart-Jones, G.B.E., Bennett, H., Boyoglu-Barnum, S., Shi, W., and Graham, B.S. (2021). mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv.","DOI":"10.1101\/2021.01.25.427948"},{"key":"ref_104","unstructured":"Madhi, S.A., Baillie, V., Cutland, C.L., Voysey, M., Koen, A.L., Fairlie, L., Padayachee, S.D., Dheda, K., Barnabas, S.L., and Bhorat, Q.E. (2021). Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(21)00191-4","article-title":"Sputnik V COVID-19 vaccine candidate appears safe and effective","volume":"397","author":"Jones","year":"2021","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.n897","article-title":"Covid-19: All Johnson and Johnson vaccine in use is safe, says US regulator","volume":"373","author":"Tanne","year":"2021","journal-title":"BMJ"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies 1 by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Xie, X., Zou, J., Fontes-Garfias, C.R., Xia, H., Swanson, K.A., Cutler, M., Cooper, D., Menachery, V.D., Weaver, S., and Dormitzer, P.R. (2021). Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. bioRxiv.","DOI":"10.1101\/2021.01.07.425740"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Andreano, E., Piccini, G., Licastro, D., Casalino, L., Johnson, N.V., Paciello, I., Monego, S.D., Pantano, E., Manganaro, N., and Manenti, A. (2020). SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. bioRxiv.","DOI":"10.1101\/2020.12.28.424451"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.n579","article-title":"Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: Matched cohort study","volume":"372","author":"Challen","year":"2021","journal-title":"BMJ"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines-a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Fay, E.J., and Langlois, R.A. (2018). MicroRNA-Attenuated virus vaccines. Non-Coding RNA, 4.","DOI":"10.3390\/ncrna4040025"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.2174\/1381612822666160720165613","article-title":"Development of Novel miRNA-based Vaccines and Antivirals against Enterovirus 71","volume":"22","author":"Yee","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2006.03.043","article-title":"Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex","volume":"125","author":"Han","year":"2006","journal-title":"Cell"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Catalanotto, C., Cogoni, C., and Zardo, G. (2016). MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101712"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2007.07.039","article-title":"Antiviral Immunity Directed by Small RNAs","volume":"130","author":"Ding","year":"2007","journal-title":"Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"110203","DOI":"10.1016\/j.mehy.2020.110203","article-title":"A new approach for COVID-19 treatment by micro-RNA","volume":"143","author":"Elhiti","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41598-017-01167-8","article-title":"MicroRNA expression profiling defines the impact of electronic cigarettes on human airway epithelial cells","volume":"7","author":"Solleti","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1586\/1744666X.2014.913482","article-title":"MicroRNAs and the immune response to respiratory virus infections","volume":"10","author":"Kowalski","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"107204","DOI":"10.1016\/j.intimp.2020.107204","article-title":"The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"90","author":"Mirzaei","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Investig. New Drugs"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-018-0004-7","article-title":"microRNAs in viral acute respiratory infections: Immune regulation, biomarkers, therapy, and vaccines","volume":"1","author":"Zeng","year":"2019","journal-title":"ExRNA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"104417","DOI":"10.1016\/j.meegid.2020.104417","article-title":"What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?","volume":"85","author":"Guterres","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/bmc-2014-0012","article-title":"Update on non-canonical microRNAs","volume":"5","author":"Abdelfattah","year":"2014","journal-title":"Biomol. Concepts"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"L444","DOI":"10.1152\/ajplung.00252.2020","article-title":"SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs","volume":"319","author":"Bartoszewski","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay, D., and Mussa, B.M. (2020). Identification of novel hypothalamic micrornas as promising therapeutics for sars-cov-2 by regulating ace2 and tmprss2 expression: An in silico analysis. Brain Sci., 10.","DOI":"10.3390\/brainsci10100666"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Pierce, J.B., Simion, V., Icli, B., P\u00e9rez-Cremades, D., Cheng, H.S., and Feinberg, M.W. (2020). Computational analysis of targeting SARS-CoV-2, viral entry proteins ace2 and tmprss2, and interferon genes by host micrornas. Genes (Basel), 11.","DOI":"10.3390\/genes11111354"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Chow, J.T.-S., and Salmena, L. (2020). Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium. Genes (Basel), 11.","DOI":"10.20944\/preprints202008.0253.v1"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fgene.2018.00439","article-title":"On the importance of host MicroRNAs during viral infection","volume":"9","author":"Girardi","year":"2018","journal-title":"Front. Genet."},{"key":"ref_135","first-page":"133","article-title":"Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections","volume":"30","author":"AlHajri","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","article-title":"MicroRNA Regulation of RNA Virus Replication and Pathogenesis","volume":"23","author":"Trobaugh","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fgene.2020.00765","article-title":"Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19","volume":"11","author":"Khan","year":"2020","journal-title":"Front. Genet."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/bib\/bbab062","article-title":"The miRNA: A small but powerful RNA for COVID-19","volume":"22","author":"Zhang","year":"2021","journal-title":"Brief Bioinform."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s10038-020-0808-9","article-title":"SARS-CoV-2 genomic variations associated with mortality rate of COVID-19","volume":"65","author":"Toyoshima","year":"2020","journal-title":"J. Hum. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review","volume":"173","author":"Oran","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_141","unstructured":"(2021, April 17). GISAID\u2014Initiative. Available online: https:\/\/www.gisaid.org\/."},{"key":"ref_142","first-page":"053","article-title":"Systematic Review of microRNAs in the SARS-CoV-2 Infection: Are microRNAs Potential Therapy for COVID-19?","volume":"8","author":"Sevgin","year":"2021","journal-title":"J. Genet. Genome Res."},{"key":"ref_143","unstructured":"(2021, April 17). miRBase. Available online: http:\/\/www.mirbase.org\/."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1093\/nar\/gkx706","article-title":"A comprehensive, cell specific microRNA catalogue of human peripheral blood","volume":"45","author":"Juzenas","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.cr.7290371","article-title":"siRNA, miRNA and HIV: Promises and challenges","volume":"15","author":"Yeung","year":"2005","journal-title":"Cell Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/JVI.02203-09","article-title":"MicroRNA Expression and Virulence in Pandemic Influenza Virus-Infected Mice","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells, 9.","DOI":"10.3390\/cells9020276"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14787210.2020.1812385","article-title":"COVID-19: Fighting the invisible enemy with microRNA","volume":"19","author":"Jaggi","year":"2021","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1002\/ctm2.200","article-title":"The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19","volume":"10","author":"Tang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ofid\/ofv100","article-title":"Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial","volume":"2","author":"McLean","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/wrna.1120","article-title":"Potential pitfalls in microRNA profiling","volume":"3","author":"Chugh","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2018.04.002","article-title":"mircoRNA-3162-3p is a potential biomarker to identify new infections in HIV-1-infected patients","volume":"662","author":"Huang","year":"2018","journal-title":"Gene"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QAI.0000000000001070","article-title":"Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals","volume":"73","author":"Yahyaei","year":"2016","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ebiom.2019.04.023","article-title":"Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection","volume":"43","author":"Biswas","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Cui, L., Qi, Y., Li, H., Ge, Y., Zhao, K., Qi, X., Guo, X., Shi, Z., Zhou, M., and Zhu, B. (2011). Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027071"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"El-Radhi, A.S. (2018). Fever in Common Infectious Diseases. Clin. Man. Fever Child., 85\u2013140.","DOI":"10.1007\/978-3-319-92336-9_5"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.00200-06","article-title":"Prediction and Identification of Herpes Simplex Virus 1-Encoded MicroRNAs","volume":"80","author":"Cui","year":"2006","journal-title":"J. Virol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07103","article-title":"MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs","volume":"454","author":"Umbach","year":"2008","journal-title":"Nature"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4049\/jimmunol.1301648","article-title":"Induction of Endotoxin Tolerance by Pathogenic Neisseria Is Correlated with the Inflammatory Potential of Lipooligosaccharides and Regulated by MicroRNA-146a","volume":"192","author":"Liu","year":"2014","journal-title":"J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Kocerha, J., Kouri, N., Baker, M., Finch, N.C., DeJesus-Hernandez, M., Gonzalez, J., Chidamparam, K., Josephs, K.A., Boeve, B.F., and Graff-Radford, N.R. (2011). Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-527"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2016.00017","article-title":"Frontotemporal lobar degeneration and microRNAs","volume":"8","author":"Piscopo","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: Cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front. Genet."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.chom.2016.02.007","article-title":"A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration","volume":"19","author":"Scheel","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.chom.2014.12.014","article-title":"MiR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation","volume":"17","author":"Masaki","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12974-015-0249-0","article-title":"miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells","volume":"12","author":"Sharma","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Ho, B.C., Yang, P.C., and Yu, S.L. (2016). MicroRNA and pathogenesis of enterovirus infection. Viruses, 8.","DOI":"10.3390\/v8010011"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02608-15","article-title":"Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication","volume":"90","author":"Slonchak","year":"2016","journal-title":"J. Virol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.micinf.2014.08.011","article-title":"MiR-223 inhibits dengue virus replication by negatively regulating the microtubule-destabilizing protein STMN1 in EAhy926cells","volume":"16","author":"Wu","year":"2014","journal-title":"Microbes Infect."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fmicb.2017.00824","article-title":"Viruses and miRNAs: More friends than foes","volume":"8","author":"Bruscella","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: A comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/156652411794859250","article-title":"Practical Aspects of microRNA Target Prediction","volume":"11","author":"Witkos","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"ref_177","unstructured":"(2021, April 17). TargetScanHuman 7.2. Available online: http:\/\/www.targetscan.org\/vert_72\/."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Riffo-Campos, \u00c1.L., Riquelme, I., and Brebi-Mieville, P. (2016). Tools for sequence-based miRNA target prediction: What to choose?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17121987"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Lekprasert, P., Mayhew, M., and Ohler, U. (2011). Assessing the utility of thermodynamic features for microRNA target prediction under relaxed seed and no conservation requirements. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020622"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"571274","DOI":"10.3389\/fgene.2020.571274","article-title":"Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis","volume":"11","author":"Sardar","year":"2020","journal-title":"Front. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"105057","DOI":"10.1016\/j.micpath.2021.105057","article-title":"Potential biomarkers for the early prediction of SARS-COV-2 disease outcome","volume":"158","author":"Mariappan","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, A., and Baric, R.S. (2017). Epigenetic landscape during coronavirus infection. Pathogens, 6.","DOI":"10.3390\/pathogens6010008"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajpath.2016.11.011","article-title":"Modulation of Antiviral Immunity by Heme Oxygenase-1","volume":"187","author":"Espinoza","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2010.10.002","article-title":"Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation","volume":"409","author":"Danesh","year":"2011","journal-title":"Virology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1128\/JVI.00456-10","article-title":"Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells","volume":"84","author":"Song","year":"2010","journal-title":"J. Virol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/v6041525","article-title":"Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans","volume":"6","author":"Zhu","year":"2014","journal-title":"Viruses"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"100407","DOI":"10.1016\/j.imu.2020.100407","article-title":"Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors","volume":"20","author":"Balmeh","year":"2020","journal-title":"Informatics Med. Unlocked"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"509","DOI":"10.14336\/AD.2020.0428","article-title":"COVID-19 virulence in aged patients might be impacted by the host cellular MicroRNAs abundance\/profile","volume":"11","author":"Fulzele","year":"2020","journal-title":"Aging Dis."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Ivashchenko, A., Rakhmetullina, A., and Aisina, D. (2020). How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV. Res. Sq., rs.3.rs-16264.","DOI":"10.21203\/rs.3.rs-16264\/v1"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Hosseini Rad SM, A., and McLellan, A.D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. Int. J. Mol. Sci., 21.","DOI":"10.1101\/2020.05.15.098947"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4939-9207-2_16","article-title":"Inconsistencies and Limitations of Current MicroRNA Target Identification Methods","volume":"1970","author":"Mockly","year":"2019","journal-title":"Met. Mol. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Liu, W., and Wang, X. (2019). Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1629-z"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gr.205146.116","article-title":"MicroRNA target prediction programs predict many false positives","volume":"27","author":"Li","year":"2017","journal-title":"Genome Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.2926","article-title":"Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury","volume":"37","author":"Tsuji","year":"2019","journal-title":"Stem Cells"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2017.05.007","article-title":"High-throughput screening and bioinformatic analysis to ascertain compounds that prevent saturated fatty acid-induced \u03b2-cell apoptosis","volume":"138","author":"Lee","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"102151","DOI":"10.1016\/j.isci.2021.102151","article-title":"Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy","volume":"24","author":"Wyler","year":"2021","journal-title":"iScience"},{"key":"ref_198","first-page":"1","article-title":"Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7","volume":"6","author":"Xie","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2217\/fvl-2020-0087","article-title":"Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection","volume":"15","author":"Tan","year":"2020","journal-title":"Future Virol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","article-title":"Incubation periods of acute respiratory viral infections: A systematic review","volume":"9","author":"Lessler","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/infdis\/jiab075","article-title":"Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection","volume":"223","author":"Tarhini","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host","volume":"383","author":"Choi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient","volume":"223","author":"Baang","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fmicb.2020.01197","article-title":"MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing","volume":"11","author":"Tribolet","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/cvr\/cvaa160","article-title":"Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab","volume":"116","author":"Wenzel","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/celldisc.2017.21","article-title":"MiRNA-200c-3p is crucial in acute respiratory distress syndrome","volume":"3","author":"Liu","year":"2017","journal-title":"Cell Discov."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yjmcc.2020.08.017","article-title":"MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes","volume":"148","author":"Lu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40292-021-00439-9","article-title":"Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update","volume":"28","author":"Shukla","year":"2021","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF03256383","article-title":"Exploiting the therapeutic potential of microRNAs in viral diseases: Expectations and limitations","volume":"14","author":"Hemida","year":"2010","journal-title":"Mol. Diagn. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","article-title":"The renin angiotensin aldosterone system and insulin resistance in humans","volume":"15","author":"Underwood","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/CS20200752","article-title":"ACE2 and energy metabolism: The connection between COVID-19 and chronic metabolic disorders","volume":"135","author":"Cao","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jclinpath-2020-206987","article-title":"Gene of the month: TMPRSS2 (transmembrane serine protease 2)","volume":"73","author":"Thunders","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3343\/alm.2021.41.2.129","article-title":"Role of genetic variants and gene expression in the susceptibility and severity of COVID-19","volume":"41","author":"Choudhary","year":"2020","journal-title":"Ann. Lab. Med."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Nersisyan, S., Shkurnikov, M., Turchinovich, A., Knyazev, E., and Tonevitsky, A. (2020). Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235987"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Matarese, A., Gambardella, J., Sardu, C., and Santulli, G. (2020). MiR-98 regulates tmprss2 expression in human endothelial cells: Key implications for covid-19. Biomedicines, 8.","DOI":"10.3390\/biomedicines8110462"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1177\/0271678X19882264","article-title":"miR-98 reduces endothelial dysfunction by protecting blood\u2013brain barrier (BBB) and improves neurological outcomes in mouse ischemia\/reperfusion stroke model","volume":"40","author":"Bernstein","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3892\/etm.2017.4171","article-title":"Microrna-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1","volume":"13","author":"Chen","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Chan, H.W., Yang, B., Wong, W., Blakeley, P., Seah, I., Tan, Q.S.W., Wang, H., Bhargava, M., Lin, H.A., and Chai, C.H. (2020). A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092920"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbrc.2015.09.058","article-title":"miR-98 protects endothelial cells against hypoxia\/reoxygenation induced-apoptosis by targeting caspase-3","volume":"467","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13054-020-2833-7","article-title":"Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan","volume":"24","author":"Shi","year":"2020","journal-title":"Crit. Care"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.18632\/aging.103415","article-title":"ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy","volume":"12","author":"Asselta","year":"2020","journal-title":"Aging"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.mayocp.2020.06.018","article-title":"Targeting TMPRSS2 in SARS-CoV-2 Infection","volume":"95","author":"Baughn","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_229","first-page":"152","article-title":"Gender differences in patients with COVID-19: Focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"medRxiv"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","article-title":"ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19","volume":"222","author":"Pinto","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/07391102.2014.938247","article-title":"HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells","volume":"33","author":"Ganai","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Beacon, T.H., Delcuve, G.P., and Davie, J.R. (2020). Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus 1. Genome, 1\u201314.","DOI":"10.1139\/gen-2020-0124"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"198275","DOI":"10.1016\/j.virusres.2020.198275","article-title":"Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint","volume":"294","author":"Kaur","year":"2021","journal-title":"Virus Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"107641","DOI":"10.1016\/j.intimp.2021.107641","article-title":"Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC","volume":"97","author":"Donyavi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_235","first-page":"122","article-title":"Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients","volume":"21","author":"Pinilla","year":"2021","journal-title":"Transl. Res."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Fayyad-Kazan, M., Makki, R., Skafi, N., El Homsi, M., Hamade, A., El Majzoub, R., Hamade, E., Fayyad-Kazan, H., and Badran, B. (2021). Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect. Genet. Evol., 105020.","DOI":"10.1016\/j.meegid.2021.105020"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"111413","DOI":"10.1016\/j.mad.2020.111413","article-title":"Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients","volume":"193","author":"Sabbatinelli","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e23590","DOI":"10.1002\/jcla.23590","article-title":"Differential microRNA expression in the peripheral blood from human patients with COVID-19","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ejhf.2096","article-title":"Circulating cardiovascular microRNAs in critically ill COVID-19 patients","volume":"3","author":"Garg","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Farr, R., Cheng, A., and Kedzierska, K. (2021). Altered microRNA expression in COVID-19 patients enables identication of SARS-CoV-2 infection. Res. Sq.","DOI":"10.21203\/rs.3.rs-253459\/v1"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/ajplung.00457.2020","article-title":"Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients","volume":"320","author":"Centa","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"McDonald, J.T., Javier Enguita, F., Taylor, D., Griffin, R.J., Priebe, W., Emmett, M.R., McGrath, M., Sajadi, M.M., Clement, J., and Dybas, J.M. (2021). The Great Deceiver: miR-2392\u2019s Hidden Role in Driving SARS-CoV-2 Infection. bioRxiv.","DOI":"10.1101\/2021.04.23.441024"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Papannarao, J.B., Schwenke, D.O., Manning, P., and Katare, R. (2021). Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19. medRxiv.","DOI":"10.1101\/2021.03.29.21254517"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2005.10.019","article-title":"The DEAD-box protein family of RNA helicases","volume":"367","author":"Cordin","year":"2006","journal-title":"Gene"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1097-2765(01)00329-X","article-title":"DEAD box RNA helicases: From generic motors to specific dissociation functions","volume":"8","author":"Tanner","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Taschuk, F., and Cherry, S. (2020). DEAD-box helicases: Sensors, regulators, and effectors for antiviral defense. Viruses, 12.","DOI":"10.3390\/v12020181"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"33197","DOI":"10.18632\/oncotarget.16593","article-title":"(DEAD)-box RNA helicase 3 modulates NF-\u03baB signal pathway by controlling the phosphorylation of PP2A-C subunit","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2013.05.026","article-title":"DDX17 promotes the production of infectious HIV-1 particles through modulating viral RNA packaging and translation frameshift","volume":"443","author":"Lorgeoux","year":"2013","journal-title":"Virology"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Cheng, W., Chen, G., Jia, H., He, X., and Jing, Z. (2018). DDX5 RNA helicases: Emerging roles in viral infection. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041122"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"602162","DOI":"10.3389\/fchem.2020.602162","article-title":"Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins","volume":"8","author":"Squeglia","year":"2020","journal-title":"Front. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"198352","DOI":"10.1016\/j.virusres.2021.198352","article-title":"DEAD-box RNA helicases: The driving forces behind RNA metabolism at the crossroad of viral replication and antiviral innate immunity","volume":"296","author":"Ali","year":"2021","journal-title":"Virus Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/15476286.2017.1405210","article-title":"Emerging roles of DROSHA beyond primary microRNA processing","volume":"15","author":"Lee","year":"2018","journal-title":"RNA Biol."},{"key":"ref_253","first-page":"381","article-title":"Mechanisms of control of microRNA biogenesis","volume":"148","author":"Hata","year":"2010","journal-title":"J. Biochem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2007.05.014","article-title":"Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 Expression","volume":"27","author":"Otsuka","year":"2007","journal-title":"Immunity"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Ostermann, E., Tuddenham, L., Macquin, C., Alsaleh, G., Schreiber-Becker, J., Tanguy, M., Bahram, S., Pfeffer, S., and Georgel, P. (2012). Deregulation of type I IFN-dependent genes correlates with increased susceptibility to cytomegalovirus acute infection of dicer mutant mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043744"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.omtn.2019.07.002","article-title":"The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer","volume":"17","author":"Wang","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.18632\/oncotarget.3046","article-title":"Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fcell.2020.00143","article-title":"MicroRNA Involvement in Signaling Pathways During Viral Infection","volume":"8","author":"Barbu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2020.09.001","article-title":"AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm","volume":"58","author":"Gangemi","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3389\/fphar.2020.602999","article-title":"Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm","volume":"11","author":"Desjarlais","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Dasgupta, I., and Chatterjee, A. (2021). Recent Advances in miRNA Delivery Systems. Methods Protoc., 4.","DOI":"10.3390\/mps4010010"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s13346-019-00645-y","article-title":"Delivery of therapeutic miRNA using polymer-based formulation","volume":"9","author":"Ban","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2230-973X.167646","article-title":"An overview of viral and nonviral delivery systems for microRNA","volume":"5","author":"Yang","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"O\u2019Neill, C.P., and Dwyer, R.M. (2020). Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy. Cells, 9.","DOI":"10.3390\/cells9020521"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425247.2010.513969","article-title":"Lipid and polymeric carrier-mediated nucleic acid delivery","volume":"7","author":"Zhu","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/15476286.2020.1730081","article-title":"Transfection of hard-to-transfect primary human macrophages with Bax siRNA to reverse Resveratrol-induced apoptosis","volume":"17","author":"Dong","year":"2020","journal-title":"RNA Biol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1038\/srep17184","article-title":"RNA-based, transient modulation of gene expression in human haematopoietic stem and progenitor cells","volume":"5","author":"Diener","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"e1134415","DOI":"10.1080\/21688370.2015.1134415","article-title":"Plant derived edible nanoparticles as a new therapeutic approach against diseases","volume":"4","author":"Zhang","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"115425","DOI":"10.1016\/j.taap.2021.115425","article-title":"Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2","volume":"414","author":"Kalarikkal","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Bernier, A., and Sagan, S.M. (2018). The diverse roles of microRNAs at the host\u2013virus interface. Viruses, 10.","DOI":"10.3390\/v10080440"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:44:42Z","timestamp":1760165082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":271,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168663"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168663","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}